Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00172
|
|||||
| Drug Name |
Uric acid
|
|||||
| Synonyms |
urate
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Acute ischemic stroke [ICD11: 8B11] | Phase 2/3 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C5H4N4O3
|
|||||
| Canonical SMILES |
C12=C(NC(=O)N1)NC(=O)NC2=O
|
|||||
| InChI |
InChI=1S/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12)
|
|||||
| InChIKey |
LEHOTFFKMJEONL-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 69-93-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 168.11 | Topological Polar Surface Area | 99.3 | ||
| Heavy Atom Count | 12 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
-1.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103023909
, 103209253
, 104296981
, 104667154
, 10533245
, 117647145
, 118496658
, 124361506
, 124403853
, 125537295
, 15219467
, 15321837
, 24439524
, 24900620
, 24900634
, 26736256
, 26744389
, 26744398
, 26744402
, 26744403
, 3136963
, 3273
, 3657
, 46392403
, 46505972
, 49703316
, 49748665
, 50061717
, 50125767
, 50126454
, 53788127
, 5428230
, 57320794
, 589184
, 610605
, 6169533
, 70376
, 78578511
, 7891020
, 8036878
, 8144012
, 8151010
, 83616204
, 841790
, 85090304
, 85164958
, 87577749
, 88828756
, 92297983
, 93578147
|
|||||
| ChEBI ID |
CHEBI:17775
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| MCT9 | Transporter Info | Monocarboxylate transporter 9 | Substrate | [3] | ||
| OAT1 | Transporter Info | Organic anion transporter 1 | Substrate | [4] | ||
| OAT3 | Transporter Info | Organic anion transporter 3 | Substrate | [4] | ||
| OAT4 | Transporter Info | Organic anion transporter 4 | Substrate | [4] | ||
| URAT1 | Transporter Info | Urate anion exchanger 1 | Substrate | [5] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | OAT1 | Transporter Info | Km = 197.6 microM | Human embryonic kidney cells (HEK293)-OAT1 | [4] | |
| OAT1 | Transporter Info | Km = 947 microM | Proximal tubule (S2) cells-OAT1 | [6] | ||
| OAT3 | Transporter Info | Km = 380.3 microM | Human embryonic kidney cells (HEK293)-OAT3 | [4] | ||
| OAT4 | Transporter Info | Km = 106 microM | Human embryonic kidney cells (HEK293)-OAT4 | [4] | ||
| URAT1 | Transporter Info | Km = 357.6 microM | Oocytes-URAT1 | [5] | ||
| References | ||||||
| 1 | ClinicalTrials.gov (NCT00860366) Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke | |||||
| 2 | Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2. PLoS One. 2012;7(2):e30456. | |||||
| 3 | Common missense variant of monocarboxylate transporter 9 (MCT9/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility. Hum Cell. 2013 Dec;26(4):133-6. | |||||
| 4 | Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers. Pharm Res. 2008 Mar;25(3):639-46. | |||||
| 5 | Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter. J Pharmacol Exp Ther. 2007 Jan;320(1):211-7. | |||||
| 6 | Urate transport via human PAH transporter hOAT1 and its gene structure. Kidney Int. 2003 Jan;63(1):143-55. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.